Multi-Center, Open-Label, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2018
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 16 May 2018 Status changed from active, no longer recruiting to completed.
- 20 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 26 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History